CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018.
Jennifer S LeeElizabeth A HumesBrenna C HoganKate BuchaczJoseph J EronM John GillTimothy R SterlingPeter F RebeiroViviane Dias LimaAngel MayorMichael J SilverbergMichael A HorbergRichard D MooreKeri N Althoffnull nullPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
From 2005 to 2018, among 32013 adults with human immunodeficiency virus entering care, median time to antiretroviral therapy (ART) prescription declined from 69 to 6 days, CD4 count at entry into care increased from 300 to 362 cells/μL, and CD4 count at ART prescription increased from 160 to 364 cells/μL.
Keyphrases
- human immunodeficiency virus
- antiretroviral therapy
- hiv infected
- hiv infected patients
- hiv positive
- hiv aids
- induced apoptosis
- healthcare
- hepatitis c virus
- palliative care
- quality improvement
- cell cycle arrest
- peripheral blood
- pain management
- affordable care act
- nk cells
- endoplasmic reticulum stress
- oxidative stress